Thailand Genetic Testing Market Report Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

Thailand genetic testing market, valued at USD 283 million, grows due to increasing genetic disorder awareness, technological advancements, and demand for preventive healthcare solutions.

Region:Asia

Author(s):Geetanshi

Product Code:KRAE1919

Pages:97

Published On:February 2026

About the Report

Base Year 2024

Thailand Genetic Testing Market Overview

  • The Thailand Genetic Testing Market is valued at approximately USD 283 million, based on current market analysis. This growth is primarily driven by increasing awareness of genetic disorders, advancements in technology, and the rising prevalence of chronic diseases. The demand for genetic testing services has surged as healthcare providers and patients seek personalized medicine solutions and preventive healthcare strategies.
  • Key players in this market include Bangkok Genomics, Chulalongkorn University, and Siriraj Hospital. These institutions dominate the market due to their advanced research capabilities, established healthcare infrastructure, and strong collaborations with international genetic testing companies, which enhance their service offerings and market reach.
  • Thailand's healthcare system has progressively integrated genetic testing into clinical practice through government-supported initiatives and institutional frameworks. The Ministry of Public Health and leading medical institutions have established protocols to improve early diagnosis and treatment of genetic disorders, with ongoing investment in genomic research infrastructure and capacity building to support the expansion of genetic testing services across the country.
Thailand Genetic Testing Market Size

Thailand Genetic Testing Market Segmentation

By Type:The genetic testing market can be segmented into various types, including diagnostic testing, predictive testing, carrier testing, prenatal testing, newborn screening, pharmacogenomic testing, and others. Each of these subsegments plays a crucial role in addressing specific healthcare needs, with diagnostic testing being the most widely utilized due to its direct application in disease identification and management. Diagnostic testing demonstrated the fastest growth trajectory among all testing categories.

Thailand Genetic Testing Market segmentation by Type.

By End-User:The end-user segmentation includes hospitals, diagnostic laboratories, research institutions, direct-to-consumer services, and others. Hospitals are the primary end-users, as they require genetic testing for patient diagnosis and treatment, while diagnostic laboratories play a significant role in providing specialized testing services. Hospitals demonstrated the fastest growth rate among end-user categories.

Thailand Genetic Testing Market segmentation by End-User.

Thailand Genetic Testing Market Competitive Landscape

The Thailand Genetic Testing Market is characterized by a dynamic mix of regional and international players. Leading participants such as Bangkok Genomics, GeneLab, Chulalongkorn University, Siriraj Hospital, Piyavate Hospital, Bangkok Hospital, Thonburi Healthcare Group, Genetica, MedGenome, Bionet, Pathogenomix, Genomics Thailand, HealthGen, Genomic Health, Genomics for Life contribute to innovation, geographic expansion, and service delivery in this space.

Bangkok Genomics

2015

Bangkok, Thailand

GeneLab

2010

Bangkok, Thailand

Chulalongkorn University

1917

Bangkok, Thailand

Siriraj Hospital

1888

Bangkok, Thailand

Piyavate Hospital

1994

Bangkok, Thailand

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate

Market Penetration Rate

Customer Retention Rate

Pricing Strategy

Product Diversification Index

Thailand Genetic Testing Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Genetic Disorders:The rise in genetic disorders in Thailand is significant, with approximately 1 in 1,000 births affected by conditions such as thalassemia and cystic fibrosis. The Thai Ministry of Public Health reported that around 22,000 new cases of thalassemia are diagnosed annually. This growing prevalence drives demand for genetic testing services, as families seek early diagnosis and management options, thereby expanding the market for genetic testing solutions in the region.
  • Rising Awareness about Personalized Medicine:The Thai population is increasingly aware of personalized medicine, with a reported 65% of individuals expressing interest in genetic testing for tailored healthcare solutions. This awareness is fueled by educational campaigns and the availability of information through digital platforms. As a result, healthcare providers are integrating genetic testing into routine care, enhancing patient outcomes and driving market growth in the genetic testing sector.
  • Advancements in Genetic Testing Technologies:Technological innovations in genetic testing, such as next-generation sequencing (NGS), have made testing more accessible and efficient. In future, the cost of whole-genome sequencing is projected to drop to around THB 28,000 (approximately USD 840), making it more affordable for the average Thai citizen. These advancements not only improve accuracy but also increase the range of tests available, further propelling market growth in Thailand.

Market Challenges

  • High Costs Associated with Genetic Testing:Despite advancements, the high costs of genetic testing remain a significant barrier. The average price for comprehensive genetic tests can reach THB 48,000 (approximately USD 1,440), which is prohibitive for many families. This financial burden limits access to essential testing services, particularly among lower-income populations, thereby hindering overall market growth in Thailand's genetic testing landscape.
  • Limited Access to Testing Facilities in Rural Areas:Access to genetic testing facilities is uneven across Thailand, with rural areas facing significant shortages. Approximately 75% of genetic testing services are concentrated in urban centers like Bangkok, leaving rural populations underserved. This disparity creates a challenge for equitable healthcare access, as many individuals in remote regions cannot obtain necessary genetic tests, limiting the market's potential for growth.

Thailand Genetic Testing Market Future Outlook

The future of the genetic testing market in Thailand appears promising, driven by technological advancements and increasing public interest in personalized healthcare. As telehealth services expand, more individuals will gain access to genetic counseling and testing, particularly in underserved areas. Additionally, collaborations between private companies and research institutions are expected to foster innovation, leading to the development of more affordable testing solutions that cater to the diverse needs of the population.

Market Opportunities

  • Expansion of Telehealth Services for Genetic Counseling:The growth of telehealth services presents a significant opportunity for genetic testing providers. With an estimated 35% increase in telehealth consultations in future, more patients can access genetic counseling remotely, improving testing uptake and patient engagement in genetic health management.
  • Development of Cost-Effective Testing Solutions:There is a growing demand for cost-effective genetic testing solutions, particularly for prenatal and carrier testing. By developing affordable testing options, companies can tap into a broader market segment, potentially increasing testing rates among families who previously could not afford such services, thus enhancing overall market growth.

Scope of the Report

SegmentSub-Segments
By Type

Diagnostic Testing

Predictive Testing

Carrier Testing

Prenatal Testing

Newborn Screening

Pharmacogenomic Testing

Others

By End-User

Hospitals

Diagnostic Laboratories

Research Institutions

Direct-to-Consumer

Others

By Application

Oncology

Cardiovascular Diseases

Neurological Disorders

Rare Diseases

Others

By Technology

Next-Generation Sequencing (NGS)

Polymerase Chain Reaction (PCR)

Microarray

Sanger Sequencing

Others

By Distribution Channel

Online Sales

Offline Sales

Others

By Region

Central Thailand

Northern Thailand

Northeastern Thailand

Southern Thailand

By Policy Support

Government Subsidies

Tax Incentives

Research Grants

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Public Health, Food and Drug Administration Thailand)

Manufacturers and Producers of Genetic Testing Kits

Healthcare Providers and Hospitals

Biotechnology and Pharmaceutical Companies

Health Insurance Companies

Industry Associations (e.g., Thai Biotechnology Industry Association)

Clinical Laboratories and Diagnostic Centers

Players Mentioned in the Report:

Bangkok Genomics

GeneLab

Chulalongkorn University

Siriraj Hospital

Piyavate Hospital

Bangkok Hospital

Thonburi Healthcare Group

Genetica

MedGenome

Bionet

Pathogenomix

Genomics Thailand

HealthGen

Genomic Health

Genomics for Life

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Thailand Genetic Testing Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Thailand Genetic Testing Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Thailand Genetic Testing Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of genetic disorders
3.1.2 Rising awareness about personalized medicine
3.1.3 Advancements in genetic testing technologies
3.1.4 Government initiatives promoting genetic research

3.2 Market Challenges

3.2.1 High costs associated with genetic testing
3.2.2 Limited access to testing facilities in rural areas
3.2.3 Regulatory hurdles in the approval process
3.2.4 Ethical concerns regarding genetic data privacy

3.3 Market Opportunities

3.3.1 Expansion of telehealth services for genetic counseling
3.3.2 Collaborations with research institutions
3.3.3 Development of cost-effective testing solutions
3.3.4 Growing demand for prenatal and carrier testing

3.4 Market Trends

3.4.1 Increasing integration of AI in genetic analysis
3.4.2 Shift towards direct-to-consumer genetic testing
3.4.3 Rise in multi-gene panel testing
3.4.4 Focus on preventive healthcare through genetic insights

3.5 Government Regulation

3.5.1 Implementation of genetic data protection laws
3.5.2 Guidelines for ethical genetic testing practices
3.5.3 Regulations on advertising genetic tests
3.5.4 Standards for laboratory accreditation

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Thailand Genetic Testing Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Thailand Genetic Testing Market Segmentation

8.1 By Type

8.1.1 Diagnostic Testing
8.1.2 Predictive Testing
8.1.3 Carrier Testing
8.1.4 Prenatal Testing
8.1.5 Newborn Screening
8.1.6 Pharmacogenomic Testing
8.1.7 Others

8.2 By End-User

8.2.1 Hospitals
8.2.2 Diagnostic Laboratories
8.2.3 Research Institutions
8.2.4 Direct-to-Consumer
8.2.5 Others

8.3 By Application

8.3.1 Oncology
8.3.2 Cardiovascular Diseases
8.3.3 Neurological Disorders
8.3.4 Rare Diseases
8.3.5 Others

8.4 By Technology

8.4.1 Next-Generation Sequencing (NGS)
8.4.2 Polymerase Chain Reaction (PCR)
8.4.3 Microarray
8.4.4 Sanger Sequencing
8.4.5 Others

8.5 By Distribution Channel

8.5.1 Online Sales
8.5.2 Offline Sales
8.5.3 Others

8.6 By Region

8.6.1 Central Thailand
8.6.2 Northern Thailand
8.6.3 Northeastern Thailand
8.6.4 Southern Thailand

8.7 By Policy Support

8.7.1 Government Subsidies
8.7.2 Tax Incentives
8.7.3 Research Grants
8.7.4 Others

9. Thailand Genetic Testing Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate
9.2.4 Market Penetration Rate
9.2.5 Customer Retention Rate
9.2.6 Pricing Strategy
9.2.7 Product Diversification Index
9.2.8 R&D Investment as a Percentage of Revenue
9.2.9 Brand Recognition Score
9.2.10 Customer Satisfaction Index

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Bangkok Genomics
9.5.2 GeneLab
9.5.3 Chulalongkorn University
9.5.4 Siriraj Hospital
9.5.5 Piyavate Hospital
9.5.6 Bangkok Hospital
9.5.7 Thonburi Healthcare Group
9.5.8 Genetica
9.5.9 MedGenome
9.5.10 Bionet
9.5.11 Pathogenomix
9.5.12 Genomics Thailand
9.5.13 HealthGen
9.5.14 Genomic Health
9.5.15 Genomics for Life

10. Thailand Genetic Testing Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Ministry of Public Health
10.1.2 Ministry of Education
10.1.3 Ministry of Science and Technology
10.1.4 Others

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Genetic Research Facilities
10.2.2 Funding for Public Health Initiatives
10.2.3 Collaborations with Private Sector
10.2.4 Others

10.3 Pain Point Analysis by End-User Category

10.3.1 Hospitals
10.3.2 Diagnostic Labs
10.3.3 Research Institutions
10.3.4 Others

10.4 User Readiness for Adoption

10.4.1 Awareness Levels
10.4.2 Training and Support Needs
10.4.3 Infrastructure Readiness
10.4.4 Others

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of Outcomes
10.5.2 Feedback Mechanisms
10.5.3 Scalability of Solutions
10.5.4 Others

11. Thailand Genetic Testing Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail vs Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Activity Planning
15.2.2 Milestone Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of government publications and health ministry reports on genetic testing regulations
  • Review of market reports from healthcare associations and genetic testing organizations in Thailand
  • Examination of academic journals and publications on genetic testing trends and consumer behavior

Primary Research

  • Interviews with genetic testing service providers and laboratory directors
  • Surveys conducted with healthcare professionals, including genetic counselors and physicians
  • Focus group discussions with potential consumers to gauge awareness and acceptance of genetic testing

Validation & Triangulation

  • Cross-validation of findings through multiple data sources, including industry reports and expert opinions
  • Triangulation of market data with demographic and health statistics from national databases
  • Sanity checks through expert panel reviews comprising geneticists and market analysts

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of market size based on national healthcare expenditure and genetic testing adoption rates
  • Segmentation of the market by testing type (e.g., prenatal, oncology, pharmacogenomics)
  • Incorporation of trends in personalized medicine and public health initiatives

Bottom-up Modeling

  • Collection of data on the number of genetic tests performed by leading laboratories
  • Estimation of average pricing for various genetic tests across different service providers
  • Volume x price calculations to derive revenue estimates for each segment

Forecasting & Scenario Analysis

  • Multi-factor regression analysis incorporating population growth, healthcare access, and technological advancements
  • Scenario modeling based on potential regulatory changes and public health campaigns
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Healthcare Providers120Genetic Counselors, Physicians, Lab Technicians
Consumers Interested in Genetic Testing100Potential Test Recipients, Patients with Family History
Insurance Companies40Underwriters, Policy Analysts, Claims Managers
Regulatory Bodies40Health Policy Makers, Regulatory Affairs Specialists
Academic Institutions50Researchers, Professors, Students in Genetics

Frequently Asked Questions

What is the current value of the Thailand Genetic Testing Market?

The Thailand Genetic Testing Market is valued at approximately USD 283 million. This growth is attributed to increased awareness of genetic disorders, advancements in technology, and the rising prevalence of chronic diseases, driving demand for personalized medicine and preventive healthcare solutions.

Who are the key players in the Thailand Genetic Testing Market?

What types of genetic testing are available in Thailand?

What are the main growth drivers for the Thailand Genetic Testing Market?

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022